Exact Mass: 966.3779884

Exact Mass Matches: 966.3779884

Found 26 metabolites which its exact mass value is equals to given mass value 966.3779884, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PIP2(16:0/16:2(9Z,12Z))

{[(4S,6S)-4-({[(2R)-2-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,3,5-trihydroxy-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C41H77O19P3 (966.4271682)


PIP2(16:0/16:2(9Z,12Z)) is a phosphatidylinositol bisphosphate. Phosphatidylinositol bisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a bisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol bisphosphates are generated from phosphatidylinositols which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols bisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP2(16:0/16:2(9Z,12Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of (9Z,12Z-hexadecadienoate) at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the (9Z,12Z-hexadecadienoate) moiety is derived from fish oils. The most important phosphatidylinositol bisphosphate in both quantitative and biological terms is phosphatidylinositol 4,5-bisphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP2(16:1(9Z)/16:1(9Z))

{[(4S,6S)-4-({[(2R)-2,3-bis[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2,3,5-trihydroxy-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C41H77O19P3 (966.4271682)


PIP2(16:1(9Z)/16:1(9Z)) is a phosphatidylinositol bisphosphate. Phosphatidylinositol bisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a bisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol bisphosphates are generated from phosphatidylinositols which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols bisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP2(16:1(9Z)/16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. The most important phosphatidylinositol bisphosphate in both quantitative and biological terms is phosphatidylinositol 4,5-bisphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol. [HMDB] PIP2(16:1(9Z)/16:1(9Z)) is a phosphatidylinositol bisphosphate. Phosphatidylinositol bisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a bisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol bisphosphates are generated from phosphatidylinositols which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols bisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP2(16:1(9Z)/16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. The most important phosphatidylinositol bisphosphate in both quantitative and biological terms is phosphatidylinositol 4,5-bisphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP2(16:2(9Z,12Z)/16:0)

{[(4S,6S)-4-({[(2R)-3-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]-2-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,3,5-trihydroxy-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C41H77O19P3 (966.4271682)


PIP2(16:2(9Z,12Z)/16:0) is a phosphatidylinositol bisphosphate. Phosphatidylinositol bisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a bisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol bisphosphates are generated from phosphatidylinositols which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols bisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP2(16:2(9Z,12Z)/16:0), in particular, consists of one chain of (9Z,12Z-hexadecadienoate) at the C-1 position and one chain of palmitic acid at the C-2 position. The (9Z,12Z-hexadecadienoate) moiety is derived from fish oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. The most important phosphatidylinositol bisphosphate in both quantitative and biological terms is phosphatidylinositol 4,5-bisphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

26-O-beta-D-glucopyranosyl-3-sulfo-furosta-5,25(27)-diene-1beta,3beta,22alpha,26-tetrol 1-O-[alpha-L-rhamnopyranosyl-(1->2)-O-alpha-L-arabinopyranoside]

26-O-beta-D-glucopyranosyl-3-sulfo-furosta-5,25(27)-diene-1beta,3beta,22alpha,26-tetrol 1-O-[alpha-L-rhamnopyranosyl-(1->2)-O-alpha-L-arabinopyranoside]

C44H70O21S (966.4130090000001)


   
   

26-O-beta-D-glucopyranosyl-furosta-5,25(27)-diene-1beta,3beta,22alpha,26-tetrol 1-O-[alpha-L-rhamnopyranosyl-(1->2)-O-4-sulfo-alpha-L-arabinopyranoside]

26-O-beta-D-glucopyranosyl-furosta-5,25(27)-diene-1beta,3beta,22alpha,26-tetrol 1-O-[alpha-L-rhamnopyranosyl-(1->2)-O-4-sulfo-alpha-L-arabinopyranoside]

C44H70O21S (966.4130090000001)


   
   

PIP2(32:2)

1-(9Z,12Z-Hexadecadienoate)-2-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol-3,4-bisphosphate)

C41H77O19P3 (966.4271682)


   

Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg

Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg

C40H62N12O14S (966.4228952)


   

H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-OH trifluoroacetate salt

H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-OH trifluoroacetate salt

C40H62N12O14S (966.4228952)


   
   

Trifluoroacetato[4,5-dihydro-1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]tetra(2,2-dimethylpropanenitrile)ruthenium(II) trifluoroacetate

Trifluoroacetato[4,5-dihydro-1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]tetra(2,2-dimethylpropanenitrile)ruthenium(II) trifluoroacetate

C45H62F6N6O4Ru (966.3779884)


   
   
   
   
   
   

[6-({6,16-dihydroxy-7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl}oxy)-4-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl]oxidanesulfonic acid

[6-({6,16-dihydroxy-7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl}oxy)-4-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl]oxidanesulfonic acid

C44H70O21S (966.4130090000001)


   

12-[(1s,14e,21r,22r,24s)-13-hydroxy-24-[(3-methylbutanoyl)oxy]-10-oxo-9,26,27-trioxa-12-azatricyclo[19.4.1.1¹,²²]heptacosa-12,14-dien-8-yl]-3-[(sulfooxy)methyl]-1,5,13-trioxa-2-azatridecane-1,13-disulfonic acid

12-[(1s,14e,21r,22r,24s)-13-hydroxy-24-[(3-methylbutanoyl)oxy]-10-oxo-9,26,27-trioxa-12-azatricyclo[19.4.1.1¹,²²]heptacosa-12,14-dien-8-yl]-3-[(sulfooxy)methyl]-1,5,13-trioxa-2-azatridecane-1,13-disulfonic acid

C38H66N2O20S3 (966.3370876)


   

n-{2,15-dibenzyl-6,13,16,21-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-2-hydroxy-3-(phosphonooxy)propanimidic acid

n-{2,15-dibenzyl-6,13,16,21-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-2-hydroxy-3-(phosphonooxy)propanimidic acid

C46H59N6O15P (966.3775834)


   

4-{[({5-[4-(4-carboxy-3-methoxy-2,5,6-trimethylphenoxycarbonyl)-3-methoxy-2,5,6-trimethylphenoxycarbonyl]-4,4'-dihydroxy-2'-methoxy-3,3',5',6,6'-pentamethyl-[1,1'-biphenyl]-2-yl}oxy)carbonyl]oxy}-2-methoxy-3,5,6-trimethylbenzoic acid

4-{[({5-[4-(4-carboxy-3-methoxy-2,5,6-trimethylphenoxycarbonyl)-3-methoxy-2,5,6-trimethylphenoxycarbonyl]-4,4'-dihydroxy-2'-methoxy-3,3',5',6,6'-pentamethyl-[1,1'-biphenyl]-2-yl}oxy)carbonyl]oxy}-2-methoxy-3,5,6-trimethylbenzoic acid

C53H58O17 (966.3673818)


   

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,15-dibenzyl-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-hydroxy-3-(phosphonooxy)propanimidic acid

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,15-dibenzyl-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-hydroxy-3-(phosphonooxy)propanimidic acid

C46H59N6O15P (966.3775834)


   

[14-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-6-hydroxy-7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxidanesulfonic acid

[14-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-6-hydroxy-7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxidanesulfonic acid

C44H70O21S (966.4130090000001)


   

[(3s,4r,5r,6s)-6-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,14r,16r)-6,16-dihydroxy-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl]oxy}-4-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(3s,4r,5r,6s)-6-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,14r,16r)-6,16-dihydroxy-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-14-yl]oxy}-4-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C44H70O21S (966.4130090000001)


   

[(1s,2s,4s,6r,7s,8r,9s,12s,13r,14r,16r)-14-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-hydroxy-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxidanesulfonic acid

[(1s,2s,4s,6r,7s,8r,9s,12s,13r,14r,16r)-14-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-hydroxy-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxidanesulfonic acid

C44H70O21S (966.4130090000001)


   

4-(4-{3-[4-(4-carboxy-3-methoxy-2,5,6-trimethylphenoxycarbonyl)-3-methoxy-2,5,6-trimethylphenoxy]-4,6-dihydroxy-2,5-dimethylbenzoyloxy}-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid

4-(4-{3-[4-(4-carboxy-3-methoxy-2,5,6-trimethylphenoxycarbonyl)-3-methoxy-2,5,6-trimethylphenoxy]-4,6-dihydroxy-2,5-dimethylbenzoyloxy}-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid

C53H58O17 (966.3673818)